Yokoe D S, Subramanyan G S, Nardell E, Sharnprapai S, McCray E, Platt R
Brigham and Women's Hospital, Boston, Massachusetts, USA.
Emerg Infect Dis. 1999 Nov-Dec;5(6):779-87. doi: 10.3201/eid0506.9906.
Data collected by health maintenance organizations (HMOs), which provide care for an increasing number of persons with tuberculosis (TB), may be used to complement traditional TB surveillance. We evaluated the ability of HMO-based surveillance to contribute to overall TB reporting through the use of routinely collected automated data for approximately 350,000 HMO members. During approximately 1.5 million person-years, 45 incident cases were identified in either HMO or public health department records. Eight (18%) confirmed cases had not been identified by the public health department. The most useful screening criterion (sensitivity of 89% and predictive value positive of 30%) was dispensing of two or more TB drugs. Pharmacy dispensing information routinely collected by many HMOs appears to be a useful adjunct to traditional TB surveillance, particularly for identifying cases without positive microbiologic results that may be missed by traditional public health surveillance methods.
健康维护组织(HMO)为越来越多的结核病(TB)患者提供护理,其所收集的数据可用于补充传统的结核病监测。我们通过使用为约35万名HMO成员定期收集的自动化数据,评估了基于HMO的监测对总体结核病报告的贡献能力。在约150万人年的时间里,在HMO或公共卫生部门的记录中识别出45例新发病例。8例(18%)确诊病例未被公共卫生部门识别。最有用的筛查标准(灵敏度为89%,阳性预测值为30%)是配发两种或更多种结核病药物。许多HMO定期收集的药房配药信息似乎是传统结核病监测的有用辅助手段,特别是用于识别那些可能被传统公共卫生监测方法遗漏的微生物学结果为阴性的病例。